In a research report issued today, Roth Capital analyst Debjit Chattopadhyay maintained a Buy rating on Sarepta Therapeutics Inc. (NASDAQ:SRPT) with a $22 price …
In a research report released Tuesday, Cantor analyst Youssef Squali assigned a Buy rating on Twitter Inc (NYSE:TWTR) with a $58 price target, as the …
In a research report released Tuesday, analyst Irina Rivkind of Cantor assigned a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with an $11 price target, following the presentation of results …
In a report released today, analyst Jim Breen of William Blair reaffirmed an Outperform rating on Gogo Inc (NASDAQ:GOGO), as the company announced an agreement to provide …
In a research report released Wednesday, Oppenheimer analyst Rick Schafer reiterated a Perform rating on Intel (NASDAQ:INTC), following the company’s third-quarter earnings results, posting sales/EPS …
In a report sent to investors Tuesday, William Blair analyst John Sonnier reiterated an Outperform rating on Gilead Sciences (NASDAQ:GILD), following last week’s news that the FDA …
In a research report published yesterday, Wedbush analyst Betsy Van Hees downgraded shares of Advanced Micro Devices (NYSE:AMD) from a Buy rating to …
In a research report sent to investors today, Cantor Fitzgerald analyst Irina Rivkind reiterated a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) with a $11 price target, as the …
In a research report sent to investors yesterday, Roth Capital analyst Debjit Chattopadhyay maintained a Buy rating on Alcobra Ltd (NASDAQ:ADHD), but reduced …
In a research report issued today, Roth Capital analyst Joseph Pantginis downgraded shares of Sunesis Pharmaceuticals (NASDAQ:SNSS) from a Buy to a Neutral rating and lowered …
